Clinical Trial: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Sponsor and CollaboratorsUniversity of Pennsylvania
Celgene Corporation
ContactContact: Stephen J Schuster, MD
215-614-1846
schustes@mail.med.upenn.edu
Principal InvestigatorStephen J Schuster, MD University of Pennsylvania
ClinicalTrials.gov IdentifierNCT00783367